Consequently, DMF administration alleviated muscle wasting and excessive fat accumulation in HFD-fed mice, primarily by enhancing PGC-1α activation in conjunction with increased mitochondrial function, thereby ameliorating the key features of sarcopenic obesity. This evidence concerns the gene PPARGC1A and obesity disorder.